Product Name: Human IL-1b Antibody (Gevokizumab, Research Use)
Catalog Number: NBR-0653
Target Name: IL-1b
Trade Name: Gevokizumab
Antibody Drug Description: Gevokizumab is a novel, human-engineered monoclonal anti-IL-1β antibody. We evaluated the safety and biological activity of gevokizumab in patients with type 2 diabetes. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: IL-1b
Synonyms: IL-1B; IL1-BETA; IL1F2
Target Description: Potent pro-inflammatory cytokine. Initially discovered as the major endogenous pyrogen, induces prostaglandin synthesis, neutrophil influx and activation, T-cell activation and cytokine production, B-cell activation and antibody production, and fibroblast proliferation and collagen production.
Ensembl: ENSG00000125538
Uniprot:  P01584